SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MEDX ... anybody following?
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2240 62 0 MEDX
Emcee:  Ed Offstein Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2040Thanks!! Which brings up a question to which I probably once knew the answer! scaram(o)uche-8/3/2008
2039I would have guessed Abgenix, but you are most likely correct that this used MedPseudo Biologist-8/3/2008
2038CTLA-4 blockade with ipilimumab induces significant clinical benefit in a femaleIcebrg-8/1/2008
2037assuming this is from medx.... Press Release Source: Amgen Amgen Licenses Molrkrw-7/31/2008
2036Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CIcebrg-7/26/2008
2035It pays to resign!rkrw-7/22/2008
2034Departure of Directors or Certain Officers; Compensatory Arrangements of CertainIcebrg-7/22/2008
2033Medscape: There has been a lot of interest over the past few years in exploring Icebrg-7/19/2008
2032Las Vegan First to Try Cancer Drug Posted on: Wednesday, 16 July 2008, 06:00 CDTIcebrg-7/16/2008
2031BioWa and Medarex Announce License of BioWa's COMPLEGENT(TM) Technology PRIIcebrg-7/16/2008
2030Manipulating both the inhibitory and stimulatory immune system towards the succeIcebrg-7/12/2008
2029Almost out of of genmab (5% stake left), still burning a lot of cash, these non rkrw-6/28/2008
2028CENTOCOR, INC. SUBMITS APPLICATION TO FDA REQUESTING APPROVAL OF GOLIMUMAB FOR TIcebrg-6/28/2008
2027According to a poster on the Yahoo board they sold enough shares to get under a Icebrg-6/28/2008
2026Progress in the Development of Novel Therapies for Melanoma: A Video Interview WIcebrg-6/28/2008
2025Would rather have the cash than bet on the stock? I think you'll see their orkrw-6/25/2008
2024Medarex has filed for having sold 351,691 Avant shares @ 12.35. Unclear why. AftIcebrg-6/25/2008
2023A Study of MDX-1106 to Treat Patients With Hepatitis C Infection clinicaltrialsIcebrg-6/23/2008
2022Programmed Death (PD)-1:PD-Ligand 1/PD-Ligand 2 Pathway Inhibits T Cell EffectorIcebrg-6/22/2008
2021Anti-integrin monoclonal antibody CNTO 95 enhances the therapeutic efficacy of fIcebrg-6/22/2008
2020Promising New Agents and Treatment Failures in Melanoma June 19, 2008 (Chicago,Icebrg-6/19/2008
2019Nevada Cancer Institute Begins First-in-Human Clinical Trial Trial is Seventh FiIcebrg-6/18/2008
2018UBS Investment Research Johnson & Johnson Panel recommends ustekinumab apprIcebrg-6/18/2008
2017FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatmscaram(o)uche-6/17/2008
2016US panel urges approval of J&J psoriasis drug Tue Jun 17, 2008 4:44pm EDT SIcebrg-6/17/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News